The modern biotechnology industry dawned in the 1970s, thanks to new techniques using recombinant DNA to manufacture substances such as human growth hormone and insulin. Fast forward to 2001, when the sequencing of the human genome was completed, the culmination of efforts under the Human Genome Project, first launched in 1990. That success is considered one of the most spectacular achievements in the history of science, with many experts believing it holds the key to unlocking the causes and potential cures for many genetically related diseases. A burgeoning genomics industry is hard at work attempting to make those promises come true. It's estimated that there are more than 400 biotech drug products and vaccines currently in clinical trials targeting more than 200 diseases, including various cancers, Alzheimer's disease, heart disease, diabetes, multiple sclerosis, AIDS and arthritis.
- Round 1: Lost to Minimally invasive surgery